Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AACR 2023 | Enhancing the efficacy of immunotherapy in prostate cancer

Scott Tagawa, FACP, MD, MS, Weill Cornell Medicine, New York, NY, talks on strategies to improve immunotherapies in prostate cancer. Targeting PD-(L)1 has not been as efficient as in other cancers and requires more stringent patient selection. Dr Tagawa additionally highlights potential combinations such as pembrolizumab with PSMA-targeted radiation. This interview took place at the American Association for Cancer Research (AACR) Annual Meeting 2023 in Orlando, FL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.